[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69728139D1 - Pyrrolopyrrolone als inhibitoren von neutrophiler elastase - Google Patents

Pyrrolopyrrolone als inhibitoren von neutrophiler elastase

Info

Publication number
DE69728139D1
DE69728139D1 DE69728139T DE69728139T DE69728139D1 DE 69728139 D1 DE69728139 D1 DE 69728139D1 DE 69728139 T DE69728139 T DE 69728139T DE 69728139 T DE69728139 T DE 69728139T DE 69728139 D1 DE69728139 D1 DE 69728139D1
Authority
DE
Germany
Prior art keywords
neutrophiler
pyrrolopyrrolone
elastase
inhibitors
neutrophiler elastase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69728139T
Other languages
English (en)
Other versions
DE69728139T2 (de
Inventor
Michael Dennis Dowle
Harry Finch
Lee Andrew Harrison
Graham George Adam Inglis
Martin Redpath Johnson
Simon John Fawcett Macdonald
Pritom Shah
Robin Andrew Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9606508.1A external-priority patent/GB9606508D0/en
Priority claimed from GBGB9623001.6A external-priority patent/GB9623001D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DE69728139D1 publication Critical patent/DE69728139D1/de
Publication of DE69728139T2 publication Critical patent/DE69728139T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
DE69728139T 1996-03-28 1997-03-26 Pyrrolopyrrolone als inhibitoren von neutrophiler elastase Expired - Fee Related DE69728139T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9606508.1A GB9606508D0 (en) 1996-03-28 1996-03-28 Chemical componds
GBGB9623001.6A GB9623001D0 (en) 1996-11-05 1996-11-05 Chemical compounds
PCT/EP1997/001530 WO1997036903A1 (en) 1996-03-28 1997-03-26 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Publications (2)

Publication Number Publication Date
DE69728139D1 true DE69728139D1 (de) 2004-04-22
DE69728139T2 DE69728139T2 (de) 2004-10-21

Family

ID=26309008

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69728139T Expired - Fee Related DE69728139T2 (de) 1996-03-28 1997-03-26 Pyrrolopyrrolone als inhibitoren von neutrophiler elastase

Country Status (30)

Country Link
US (3) US5994344A (de)
EP (1) EP0891362B1 (de)
JP (1) JP4118337B2 (de)
KR (1) KR20000005039A (de)
CN (1) CN1067075C (de)
AP (1) AP823A (de)
AR (1) AR006401A1 (de)
AT (1) ATE261969T1 (de)
AU (1) AU726649B2 (de)
BR (1) BR9708449A (de)
CA (1) CA2250209A1 (de)
CO (1) CO4790152A1 (de)
CZ (1) CZ309798A3 (de)
DE (1) DE69728139T2 (de)
DK (1) DK0891362T3 (de)
EA (1) EA001437B1 (de)
EE (1) EE9800335A (de)
ES (1) ES2217404T3 (de)
HU (1) HUP9900567A3 (de)
IL (1) IL125859A0 (de)
IS (1) IS4837A (de)
NO (1) NO984470L (de)
NZ (1) NZ331490A (de)
PE (1) PE55298A1 (de)
PL (1) PL329153A1 (de)
PT (1) PT891362E (de)
SK (1) SK132498A3 (de)
TR (1) TR199801935T2 (de)
WO (1) WO1997036903A1 (de)
YU (1) YU41198A (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9719189D0 (en) * 1997-09-09 1997-11-12 Glaxo Group Ltd New therapeutic method
GB9719187D0 (en) * 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
PE107899A1 (es) * 1997-09-09 1999-11-17 Glaxo Group Ltd Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria
GB9719172D0 (en) * 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
GB9821199D0 (en) * 1998-09-30 1998-11-25 Glaxo Group Ltd Chemical compounds
GB9905418D0 (en) * 1999-03-09 1999-05-05 Glaxo Group Ltd Process
AU2003216707A1 (en) * 2003-03-10 2004-09-30 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
TWI344955B (en) 2003-03-14 2011-07-11 Ono Pharmaceutical Co Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient
US8530509B2 (en) 2003-06-20 2013-09-10 Siga Technologies, Inc. Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
AU2007351866C1 (en) * 2003-06-20 2013-07-25 Siga Technologies, Inc. Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
US7692037B2 (en) * 2004-09-02 2010-04-06 Eastman Chemical Company Optimized liquid-phase oxidation
WO2006030925A1 (ja) 2004-09-13 2006-03-23 Ono Pharmaceutical Co., Ltd. 含窒素複素環誘導体およびそれらを有効成分とする薬剤
GB0512238D0 (en) * 2005-06-15 2005-07-27 Univ Cambridge Tech Anti-inflammatory agents
EP1995246A4 (de) 2006-03-10 2010-11-17 Ono Pharmaceutical Co Nitrogeniertes heterocyclisches derivat und arzneimittel mit dem derivat als wirkstoff
EA019509B1 (ru) 2007-11-16 2014-04-30 Райджел Фармасьютикалз, Инк. Карбоксамидные, сульфонамидные и аминовые соединения от метаболических нарушений
ES2553340T3 (es) 2007-12-12 2015-12-07 Rigel Pharmaceuticals, Inc. Compuestos de carboxamida, sulfonamida y amina para trastornos metabólicos
WO2009132136A1 (en) 2008-04-23 2009-10-29 Rigel Pharmaceuticals, Inc. Carboxamide compounds for the treatment of metabolic disorders
PT2935274T (pt) * 2012-12-18 2018-12-05 Chiesi Farm Spa Derivados de 3-oxo-2,3,5,8-tetrahidro-[1,2,4]triazolo[4,3- a]pirimidina para o tratamento de doenças respiratórias
CA3154761A1 (en) 2019-09-17 2021-03-25 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
HRP20231065T1 (hr) 2020-04-16 2023-12-22 Mereo Biopharma 4 Limited Postupci koji uključuju alvelestat inhibitor neutrofilne elastaze za liječenje respiratorne bolesti posredovane putem nedostatka alfa-1 antitripsina
CA3234399A1 (en) 2021-10-20 2023-04-27 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2932650A (en) * 1957-11-19 1960-04-12 Arthur C Cope 2-6-diazabicyclo (3. 3. 0) octanes
US4997950A (en) * 1989-04-20 1991-03-05 Richard Finbar Murphy Novel C-terminal gastrin antagonists
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
US5610296A (en) * 1994-12-05 1997-03-11 G. D. Searle & Co. Process for the preparation of amidino phenyl pyrrolidine beta-alanine urea analogs

Also Published As

Publication number Publication date
US5994344A (en) 1999-11-30
CA2250209A1 (en) 1997-10-09
WO1997036903A1 (en) 1997-10-09
DE69728139T2 (de) 2004-10-21
KR20000005039A (ko) 2000-01-25
EA199800773A1 (ru) 1999-06-24
CZ309798A3 (cs) 1999-02-17
AP823A (en) 2000-04-25
HUP9900567A2 (hu) 1999-06-28
IL125859A0 (en) 1999-04-11
CN1067075C (zh) 2001-06-13
EE9800335A (et) 1999-04-15
HUP9900567A3 (en) 2001-02-28
US6215002B1 (en) 2001-04-10
JP2000507950A (ja) 2000-06-27
AP9801351A0 (en) 1998-09-30
ES2217404T3 (es) 2004-11-01
EP0891362B1 (de) 2004-03-17
NO984470L (no) 1998-11-25
JP4118337B2 (ja) 2008-07-16
TR199801935T2 (xx) 1999-03-22
YU41198A (sh) 1999-09-27
AU2291797A (en) 1997-10-22
IS4837A (is) 1998-08-28
PT891362E (pt) 2004-08-31
AU726649B2 (en) 2000-11-16
SK132498A3 (en) 1999-08-06
CN1219935A (zh) 1999-06-16
EP0891362A1 (de) 1999-01-20
EA001437B1 (ru) 2001-02-26
CO4790152A1 (es) 1999-05-31
PL329153A1 (en) 1999-03-15
DK0891362T3 (da) 2004-07-12
NO984470D0 (no) 1998-09-25
US6057457A (en) 2000-05-02
ATE261969T1 (de) 2004-04-15
BR9708449A (pt) 1999-08-03
AR006401A1 (es) 1999-08-25
PE55298A1 (es) 1998-09-19
NZ331490A (en) 2000-06-23

Similar Documents

Publication Publication Date Title
DE69728139D1 (de) Pyrrolopyrrolone als inhibitoren von neutrophiler elastase
DE59710384D1 (de) Ketobenzamide als calpain-inhibitoren
DE59710982D1 (de) Cycloalkano-pyridine als CETP-Inhibitoren
DE69725465D1 (de) 6-phenylpyridyl-2-amin-derivate verwendbar als nos-inhibitoren
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
DE69735316D1 (de) Erkennung von Extravasation
ID18406A (id) Palang penggantung pakaian
DE69627179D1 (de) Substituierte 2-anilino-pyrimidines verwendbar als protein kinase inhibitoren
DE69716615D1 (de) Heterozyklische metalloproteaseinhibitoren
FI973282A0 (fi) Trombiinin inhibiittoreita
ATE267805T1 (de) Lactamverbindungen als metalloprotease- inhibitoren
DK0858464T3 (da) Thrombin-inhibitorer
PT927183E (pt) Inibidores espirociclicos de metaloproteases
ATE268781T1 (de) Thrombininhibitoren
DE69736109D1 (de) Differenzierungsinhibitor
EE200000138A (et) Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena
DE69733263D1 (de) Markierte elastase-inhibitoren
ID16838A (id) Komposisi dekafluoropentana
ATE221065T1 (de) Amidinderivate als inhibitoren von no-synthase
EE200000137A (et) Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena
DE59705708D1 (de) Lagebestimmung von peripherieeinheiten
DE69709159D1 (de) Kreuz-dimierisierung von olefinen
DE69700722D1 (de) Redistribution von Polycarbonat
DE69717631D1 (de) Bestimmung von teilchenförmigen verunreinigungen
ATE282629T1 (de) Thrombininhibitoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee